Skip to content
Colorectal Cancer Clinical Trials

Madison, Wisconsin

Colorectal cancer clinical trials in Madison, WI

28 colorectal cancer studies are recruiting participants at sites in Madison as of November 16, 2026, according to ClinicalTrials.gov. Colorectal Cancer Clinical Trials can help you understand your options and connect with a study team.

Call (888) 385-9581
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Madison at a glance

  • 28 studies are recruiting at a site in Madison.
  • By phase: Phase 1 (4), Phase 1/2 (8), Phase 2 (7), Phase 2/3 (1), Phase 3 (3), Phase 4 (1), No phase (2), Observational (2). Studies of devices and behavioral approaches have no phase.
  • By sponsor: industry (19), university, hospital or other (8), government (1).
  • Most recent update to one of these records: November 16, 2026.

Studies recruiting in Madison

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    ECOG-ACRIN Cancer Research Group
    Study sites
    University of Wisconsin Carbone Cancer Center - Eastpark Medical Center · University of Wisconsin Carbone Cancer Center - University Hospital
    Registry record
    NCT05863195 · updated
  2. A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Global Development, Inc.
    Study site
    UW Health Carbone Cancer Center
    Registry record
    NCT07488676 · updated
  3. A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Verastem, Inc.
    Study site
    University of Wisconsin
    Registry record
    NCT07659795 · updated
  4. Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Dustin Deming
    Study site
    University of Wisconsin
    Registry record
    NCT06493019 · updated
  5. Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Summit Therapeutics
    Registry record
    NCT07228832 · updated
  6. Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

    • No phase
    • Ages 45 to 70
    • All sexes
    Sponsor
    NRG Oncology
    Study site
    William S Middleton VA Medical Center
    Registry record
    NCT05080673 · updated
  7. Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

    • Phase 2/3
    • Ages 18 and older
    • All sexes
    Sponsor
    NRG Oncology
    Study sites
    University of Wisconsin Carbone Cancer Center - Eastpark Medical Center · University of Wisconsin Carbone Cancer Center - University Hospital
    Registry record
    NCT05174169 · updated
  8. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    • Observational
    • Ages 40 to 75
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study sites
    University of Wisconsin Carbone Cancer Center - Eastpark Medical Center · University of Wisconsin Carbone Cancer Center - University Hospital · William S Middleton VA Medical Center
    Registry record
    NCT05334069 · updated
  9. Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    Wake Forest University Health Sciences
    Study site
    University of Wisconsin Carbone Cancer Center - University Hospital
    Registry record
    NCT06418204 · updated
  10. A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    University of Wisconsin - Carbone Cancer Center
    Registry record
    NCT07213791 · updated
  11. A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Janssen Research & Development, LLC
    Study site
    William S. Middleton Memorial VA
    Registry record
    NCT06662786 · updated
  12. A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Study site
    Univ of Wisconsin-Madison
    Registry record
    NCT07416552 · updated
  13. A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Study site
    University Hospital and UW Health Clinics-Carbone Cancer Center ( Site 0293)
    Registry record
    NCT06428409 · updated
  14. Lead-212 PSV359 Therapy for Patients With Solid Tumors

    • Phase 1/2
    • Ages 18 to 90
    • All sexes
    Sponsor
    Perspective Therapeutics
    Study site
    University of Wisconsin
    Registry record
    NCT06710756 · updated
  15. A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    GlaxoSmithKline
    Study site
    GSK Investigational Site
    Registry record
    NCT06885034 · updated
  16. KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Kura Oncology, Inc.
    Study site
    University of Wisconsin (Carbone Cancer Center)
    Registry record
    NCT06026410 · updated
  17. FOG-001 in Locally Advanced or Metastatic Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Parabilis Medicines, Inc.
    Study site
    University of Wisconsin, Carbone Cancer Center
    Registry record
    NCT05919264 · updated
  18. The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

    • Phase 1/2
    • Ages 12 and older
    • All sexes
    Sponsor
    PMV Pharmaceuticals, Inc
    Study site
    University of Wisconsin Carbone Cancer Center
    Registry record
    NCT04585750 · updated
  19. Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
    Study site
    Wisconsin Institute for Medical Research
    Registry record
    NCT06625775 · updated
  20. Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Phanes Therapeutics
    Study site
    University of Wisconsin Carbone Cancer Center - University Hospital
    Registry record
    NCT05482893 · updated
  21. Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

    • Phase 2
    • Ages 18 to 130
    • All sexes
    Sponsor
    AstraZeneca
    Registry record
    NCT05489211 · updated
  22. Liposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    University of Wisconsin, Madison
    Study site
    University of Wisconsin Carbone Cancer Center
    Registry record
    NCT05854498 · updated
  23. An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    University of Wisconsin Carbone Cancer Center - University Hospital
    Registry record
    NCT06557733 · updated
  24. Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Medtronic - MITG
    Study site
    SSM Health St. Mary's Hospital - Madison
    Registry record
    NCT07351071 · updated
  25. A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Marengo Therapeutics, Inc.
    Study site
    University of Wisconsin- Madison
    Registry record
    NCT05592626 · updated
  26. Single Arm Study of Neoadjuvant Dostarlimab in Stage II and III Deficient Mismatch Repair Colon Cancers

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    University of Iowa
    Study site
    University of Wisconsin
    Registry record
    NCT05239546 · updated
  27. Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

    • Phase 4
    • Ages 18 to 64
    • All sexes
    Sponsor
    Guerbet
    Study site
    University of Wisconsin
    Registry record
    NCT04373564 · updated
  28. APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Apollomics Inc.
    Study site
    University of Wisconsin
    Registry record
    NCT03175224 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Madison, WI on ClinicalTrials.gov.

Ask about studies near Madison

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 385-9581

or send a short form

How should we reach you?

Call